Andreas Schröder

JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes

Georg Ostermann, Kim S. C. Weber, Alma Zernecke et al. · Nature Immunology · 2002 · 640 citations

Life Sciences, Cell Biology, Molecular Biology +14

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Charles Butts, Mark A. Socinski, Paul Mitchell et al. · The Lancet Oncology · 2013 · 526 citations · Full text

Medicine, Oncology, Pharmacology +13

Induction of cancer cell apoptosis by α‐tocopheryl succinate: molecular pathways and structural requirements

Tobias Weber, Andreas Schröder, Min Lü et al. · The FASEB Journal · 2001 · 287 citations

Life Sciences, Oncology, Pharmacology +17

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt et al. · Journal for ImmunoTherapy of Cancer · 2019 · 222 citations · Full text

Medicine, Oncology, Radiation Oncology +17

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Martin Sebastian, Andreas Schröder, Birgit Scheel et al. · Cancer Immunology Immunotherapy · 2019 · 204 citations · Full text

Medicine, Immunology, Oncology +12